Literature DB >> 7966652

The risk of rhabdomyolysis and acute renal failure with the patient in the exaggerated lithotomy position.

S A Bildsten1, R R Dmochowski, M R Spindel, J R Auman.   

Abstract

Rhabdomyolysis with subsequent renal failure has been well documented as a complication of major trauma. However, this complication from elective urological procedures is less well recognized. In 10 patients who underwent elective urethroplasty serum levels of creatine kinase and urinary myoglobin were examined preoperatively and postoperatively. These patients were placed in the lithotomy position for several hours and had minimal muscle dissection. Serum creatine kinase was noted to increase significantly postoperatively to greater than 1,000 units and in 1 patient myoglobin was detected in the urine. This finding indicates that there is, indeed, a risk of muscle injury and potential rhabdomyolysis in these patients from the use of the exaggerated lithotomy position.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966652     DOI: 10.1016/s0022-5347(17)32281-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Fatal Rhabdomyolysis following Spine Surgery in a Morbidly Obese Patient: A Case Report.

Authors:  Se Ho Jung; Seok Won Kim; Dong Min Kim; Chang Il Ju
Journal:  Korean J Spine       Date:  2014-12-31

Review 2.  Posterior Urethral Strictures.

Authors:  Joel Gelman; Eric S Wisenbaugh
Journal:  Adv Urol       Date:  2015-11-24

Review 3.  Anatomy and techniques in posterior urethroplasty.

Authors:  Reynaldo G Gomez; Kyle Scarberry
Journal:  Transl Androl Urol       Date:  2018-08

4.  Acute Renal Failure Secondary to Rhabdomyolysis as a Complication of Major Urological Surgery: The Experience of a High-Volume Urological Center.

Authors:  Armando E De Gracia-Nieto; Oriol Angerri; Jordi Bover; Daniel Salas; Juan Manuel Villamizar; Humberto Villavicencio
Journal:  Med Princ Pract       Date:  2016-03-02       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.